Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / LAB - Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships

LAB - Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships

May, 06 2025 08:08 PM Standard BioTools Inc.

2025-05-06 20:08:34 ET

More on Standard BioTools

Standard BioTools Inc. (LAB) Q1 2025 Earnings Conference Call Transcript
Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript
Standard BioTools Inc. 2024 Q4 - Results - Earnings Call Presentation
Standard BioTools GAAP EPS of -$0.07 in-line, revenue of $40.8M beats by $0.7M
Standard BioTools cut to Neutral at KeyBanc on guidance

For further details see:

Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships

Stock Information

Company Name:	Standard BioTools Inc.
Stock Symbol:	LAB
Market:	NASDAQ
Website:	fluidigm.com

LAB LAB Quote LAB Short LAB News LAB Articles LAB Message Board

Get LAB Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.